Hims & Hers Health (HIMS)
The stock for Hims & Hers Health (HIMS) is making noise lately. It's trading around $36.16, and traders are betting big that it’ll go higher soon. But what’s really going on here—and more importantly, what could be in it for you?
🐋 Get Daily Whale Alerts
🔥 Why the Stock Is Hot
Big Drug Deal with Novo Nordisk
HIMS just teamed up with Novo Nordisk to offer Wegovy, a popular weight-loss drug, through its platform. That means more people might come to HIMS for weight-loss help, and that could boost their revenue.Earnings Coming Soon
HIMS will report its latest earnings on May 5. Wall Street expects good news. The company has already hinted that it’s doing better than expected, and investors love strong numbers.Moving to Branded Meds
Now that the FDA cleared up some supply issues, HIMS is shifting from custom-made drugs to official, name-brand ones. That’s a smart move—it keeps them on the right side of the law and builds trust with customers.
💸 So What’s in It for Me?
Here’s the part that matters:
- Traders are buying tons of short-term CALLs—they’re betting HIMS is about to go up fast.
- If they’re right and earnings or this new drug deal send the stock higher, you could make a profit just by riding the wave.
- Even if you're not into trading options, the heavy bullish activity might mean there's a quick window to catch some upside.
Right now, people are aiming for $38–$40 in the next few days. If the news hits just right, that could be realistic.
👀 Final Word This looks like a momentum play. If you believe the news and hype will push HIMS higher in the short term, there might be money on the table. Just know—it’s a fast-moving setup, and momentum cuts both ways.
Want help deciding how long to hold or what price targets to watch?